Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 16 03 2023
revised: 14 09 2023
accepted: 17 09 2023
medline: 27 11 2023
pubmed: 30 9 2023
entrez: 29 9 2023
Statut: ppublish

Résumé

Loss of functional RAB18 causes the autosomal recessive condition Warburg Micro syndrome. To better understand this disease, we used proximity biotinylation to generate an inventory of potential RAB18 effectors. A restricted set of 28 RAB18 interactions were dependent on the binary RAB3GAP1-RAB3GAP2 RAB18-guanine nucleotide exchange factor complex. Twelve of these 28 interactions are supported by prior reports, and we have directly validated novel interactions with SEC22A, TMCO4, and INPP5B. Consistent with a role for RAB18 in regulating membrane contact sites, interactors included groups of microtubule/membrane-remodeling proteins, membrane-tethering and docking proteins, and lipid-modifying/transporting proteins. Two of the putative interactors, EBP and OSBPL2/ORP2, have sterol substrates. EBP is a Δ8-Δ7 sterol isomerase, and ORP2 is a lipid transport protein. This prompted us to investigate a role for RAB18 in cholesterol biosynthesis. We found that the cholesterol precursor and EBP-product lathosterol accumulates in both RAB18-null HeLa cells and RAB3GAP1-null fibroblasts derived from an affected individual. Furthermore, de novo cholesterol biosynthesis is impaired in cells in which RAB18 is absent or dysregulated or in which ORP2 expression is disrupted. Our data demonstrate that guanine nucleotide exchange factor-dependent Rab interactions are highly amenable to interrogation by proximity biotinylation and may suggest that Micro syndrome is a cholesterol biosynthesis disorder.

Identifiants

pubmed: 37774976
pii: S0021-9258(23)02323-2
doi: 10.1016/j.jbc.2023.105295
pmc: PMC10641524
pii:
doi:

Substances chimiques

Cholesterol 97C5T2UQ7J
Guanine Nucleotide Exchange Factors 0
OSBPL2 protein, human 0
rab GTP-Binding Proteins EC 3.6.5.2
RAB18 protein, human 0
rab3 GTP-Binding Proteins EC 3.6.5.2
RAB3GAP1 protein, human EC 3.6.5.2
Sterols 0
TBC1D20 protein, human 0
SEC22A protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105295

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Robert S Kiss (RS)

Cardiovascular Health Across the Lifespan (CHAL) Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: robert.kiss@mcgill.ca.

Jarred Chicoine (J)

Metabolic Disorders and Complications (MEDIC) Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Youssef Khalil (Y)

Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.

Robert Sladek (R)

Metabolic Disorders and Complications (MEDIC) Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

He Chen (H)

Cardiovascular Health Across the Lifespan (CHAL) Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Alessandro Pisaturo (A)

Cardiovascular Health Across the Lifespan (CHAL) Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Cyril Martin (C)

Cardiovascular Health Across the Lifespan (CHAL) Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Jessica D Dale (JD)

Leeds Institute of Medical Research, St James's University Hospital, Leeds, United Kingdom.

Tegan A Brudenell (TA)

Leeds Institute of Medical Research, St James's University Hospital, Leeds, United Kingdom.

Archith Kamath (A)

MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom; Division of Medical Sciences, University of Oxford, Oxford, United Kingdom.

Jeffrey Kyei-Boahen (J)

Department of Medicine, McGill University Health Centre, CHAL Research Program, Montreal, Canada.

Anouar Hafiane (A)

Department of Medicine, McGill University Health Centre, CHAL Research Program, Montreal, Canada.

Girija Daliah (G)

Department of Medicine, McGill University Health Centre, Cancer Research Program, Montreal, Canada.

Célia Alecki (C)

Department of Biochemistry, McGill University, Montreal, Quebec, Canada.

Tayah S Hopes (TS)

Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Martin Heier (M)

Department of Clinical Neuroscience for Children, Oslo University Hospital, Oslo, Norway.

Irene A Aligianis (IA)

Medical and Developmental Genetics, Medical Research Council Human Genetics Unit, Edinburgh, United Kingdom.

Jean-Jacques Lebrun (JJ)

Department of Medicine, McGill University Health Centre, Cancer Research Program, Montreal, Canada.

Julie Aspden (J)

Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.

Emanuele Paci (E)

Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.

Anja Kerksiek (A)

Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.

Dieter Lütjohann (D)

Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.

Peter Clayton (P)

Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.

Jimi C Wills (JC)

Cancer Research United Kingdom Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom; Firefinch Software Ltd, Edinburgh, United Kingdom.

Alex von Kriegsheim (A)

Cancer Research United Kingdom Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom.

Tommy Nilsson (T)

Cancer Research Program (CRP), Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Eamonn Sheridan (E)

Leeds Institute of Medical Research, St James's University Hospital, Leeds, United Kingdom.

Mark T Handley (MT)

Leeds Institute of Medical Research, St James's University Hospital, Leeds, United Kingdom; Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom. Electronic address: mark.handley@protonmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH